Risultati per: Tumore prostata, test della saliva piu’ attendibile del PSA

Bene calo restrizioni in Piemonte, Calabria e Liguria

Comunicato del 20/09/2024 n°27

Verrà sviluppato insieme all’australiana Microbio

This prospective, observational study investigates the efficacy and safety of medication abortion provided using no-test telehealth eligibility screening and mailing of medications compared with in-person care with ultrasonography in the US.

Preservata l’integrità dell’organo, migliora la qualità di vita

Più casi di mieloma e cancro a colon-retto, pesano stili di vita

De Lautentiis, ‘fondamentale migliorare il controllo a lungo termine della malattia’

‘In molti casi otteniamo la guarigione, ma la prevenzione è fondamentale’

Dal sistema immunitaria, per contrastare metastasi e recidive

Nella forma metastatica ormonosensibile

Pre e post chirurgia,-34% rischio morte. E’ forma più aggressiva

Ridotto del 32% rischio recidiva e del 25% il rischio di morte

Lorusso, per la prima volta da 20 anni questa combinazione cambia lo standard di cura

Tasso di sopravvivenza senza progressione di malattia è del 61% ad un anno

Stroke, Ahead of Print. Right-to-left shunt, mainly due to patent foramen ovale (PFO), is likely responsible for ≈5% of all ischemic strokes and 10% of those occurring in young and middle-aged adults. Randomized clinical trials demonstrated that, in selected young and middle-aged patients with otherwise cryptogenic acute ischemic stroke and high-risk PFO, percutaneous PFO closure is more effective than antiplatelet therapy alone in preventing recurrence. However, PFO is generally a benign finding and is present in about one-quarter of the population. Therefore, in clinical practice, identifying PFOs that are likely to be pathogenetic is crucial for selecting suitable patients for PFO closure to prevent recurrent stroke and to avoid potentially harmful and costly overtreatment. Contrast transthoracic echocardiography has a relatively low sensitivity in detecting PFO, whereas transesophageal echocardiography is currently considered the gold standard for PFO detection. However, it is a relatively invasive procedure and may not always be easily feasible in the subacute setting. Contrast transcranial Doppler is a noninvasive, inexpensive, accurate tool for the detection of right-to-left shunt. We conducted a literature review on the use of contrast transcranial Doppler to detect and grade right-to-left shunt after an acute ischemic stroke and present a clinical workflow proposal for young and middle-aged patients.

Donne non corrono rischio maggiore di recidiva o nuove neoplasie